General Dynamics Information Technology, a business unit of General Dynamics, was last week awarded a $41.8 million task order by the U.S. Army Medical Research Materiel Command to provide support services for vaccine, drug and medical device development programs to the U.S. Army Medical Materiel Development Activity (USAMMDA).
USAMMDA develops new drugs, vaccines and medical support devices that enhance readiness, ensure provisions of the highest quality medical care to the DoD and maximize the survival of medical casualties on the battlefield. The product managers at USAMMDA guide promising new concepts and technologies developed in the USAMRMC laboratories through advanced development and the regulatory process to obtain U.S. FDA certification. Upon FDA certification, USAMMDA works in conjunction with the U.S. Army Medical Materiel Agency to develop plans for fielding medical materiel.
General Dynamics will deliver a wide range of services in support of USAMMDA’s mission. The company has partnered with Tunnell Government Services Inc., a life sciences technical services consulting leader in biotechnology, medical devices and pharmaceutical product development, on this contract. General Dynamics anticipates hiring more than 30 new employees to perform this work at Fort Detrick in Frederick, Md.
